Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341718 · ClinicalTrials.gov registry record

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
30
Enrollment target

NCT00341718: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00341718 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341718 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information from this study may be used to enhance educational experiences in genetics clinics. Patients 18 years of age and older with a visible physical anomaly who have been seen by a genetics professional in the past 5 years may be eligible for this study. In a tape-recorded telephone interview, patients are asked about the following: * Their experiences when visiting the genetics clinic * The circumstances under which they have been approached to participate in teaching others * Their perspective on specific teaching behaviors used in genetic consultations, and how this perspective is affected by their perception of their own visible difference * The benefits and downsides of being involved in teaching others * The circumstances under which they feel comfortable being approached by genetics providers to help teach others about their condition * The conditions or circumstances that make some individual teaching experiences better or worse than others

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-03-29
Est. Completion 2007-03-31

What the finished NCT00341718 record still lists

NCT00341718 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00341718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00341718 about?

NCT00341718 is a clinical study titled "Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics". This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information from this study may be used to enhance educational experiences in genetics clinics. Patients 18 years of age an...

What is the current status of trial NCT00341718?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-03-29. Estimated completion is 2007-03-31.

Who is sponsoring clinical trial NCT00341718?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00341718, the US trial registry maintained by the National Library of Medicine. NCT00341718 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.